Ep. 65 - Astellas' Claus Zieler: Global Launches with Local Impact

The BioCentury Show

As Astellas prepares to launch four products in parallel, Chief Commercial Officer Claus Zieler is balancing the complexity of this multi-faceted enterprise with a simple guiding principle: it has to work at a local level, and that will change with geography, circumstance and time. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Zieler discusses how to factor local differences in patient behavior, payer systems and regulatory environments into a global launch strategy. He also advocates for a seamless integration of R&D and commercial efforts throughout the lifecycle of each product, from early development to loss of exclusivity, and he discusses what small companies need to know when deciding whether to commercialize a therapy on their own.
View full story: https://www.biocentury.com/article/653047
#biotech #biopharma #pharma #lifescience #RandD #deals #licensing #partnerships
00:00 - Intro
01:26 - Focus Area Approach
04:55 - Continuous Teams
09:00 - Building Partnerships
15:24 - Omni Channel Launches
28:40 - Future Pipeline

فصل ها

1. Ep. 65 - Astellas' Claus Zieler: Global Launches with Local Impact (00:00:00)

2. Focus Area Approach (00:01:26)

3. Continuous Teams (00:04:47)

4. Building Partnerships (00:08:50)

5. Omni Channel Launches (00:15:03)

6. Future Pipeline (00:28:18)